| Comparison of evidence of treatment effects in randomized and nonrandomized studies JPA Ioannidis, AB Haidich, M Pappa, N Pantazis, SI Kokori, ... Jama 286 (7), 821-830, 2001 | 994 | 2001 |
| Changes in the risk of death after HIV seroconversion compared with mortality in the general population K Bhaskaran, O Hamouda, M Sannes, F Boufassa, AM Johnson, ... Jama 300 (1), 51-59, 2008 | 677 | 2008 |
| Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy B Marin, R Thiébaut, HC Bucher, V Rondeau, D Costagliola, M Dorrucci, ... Aids 23 (13), 1743-1753, 2009 | 326 | 2009 |
| Response to combination antiretroviral therapy: variation by age Collaboration of Observational HIV Epidemiological Research Europe (COHERE ... Aids 22 (12), 1463-1473, 2008 | 272 | 2008 |
| Time From Human Immunodeficiency Virus Seroconversion to Reaching CD4+ Cell Count Thresholds <200, <350, and <500 Cells/mm3: Assessment of Need … S Lodi, A Phillips, G Touloumi, R Geskus, L Meyer, R Thiébaut, ... Clinical infectious diseases 53 (8), 817-825, 2011 | 261 | 2011 |
| The hepatitis C epidemic among HIV-positive MSM: incidence estimates from 1990 to 2007 JJ van der Helm, M Prins, J del Amo, HC Bucher, G Chêne, M Dorrucci, ... Aids 25 (8), 1083-1091, 2011 | 175 | 2011 |
| Exhaustion of activated CD8 T cells predicts disease progression in primary HIV-1 infection M Hoffmann, N Pantazis, GE Martin, S Hickling, J Hurst, J Meyerowitz, ... PLoS pathogens 12 (7), e1005661, 2016 | 170 | 2016 |
| Frequency and distribution of root filled teeth and apical periodontitis in a Greek population MK Georgopoulou, AP Spanaki‐Voreadi, N Pantazis, EG Kontakiotis International endodontic journal 38 (2), 105-111, 2005 | 170 | 2005 |
| Kaposi sarcoma incidence and survival among HIV-infected homosexual men after HIV seroconversion S Lodi, M Guiguet, D Costagliola, M Fisher, A De Luca, K Porter, ... Journal of the National Cancer Institute 102 (11), 784-792, 2010 | 157 | 2010 |
| Timing of HAART initiation and clinical outcomes among HIV-1 seroconverters MJ Funk, JS Fusco, SR Cole, JC Thomas, K Porter, JS Kaufman, ... Archives of internal medicine 171 (17), 1560, 2011 | 152 | 2011 |
| High levels of postmigration HIV acquisition within nine European countries D Alvarez-del Arco, I Fakoya, C Thomadakis, N Pantazis, G Touloumi, ... Aids 31 (14), 1979-1988, 2017 | 135 | 2017 |
| Impact of HIV-1 subtype on CD4 count at HIV seroconversion, rate of decline, and viral load set point in European seroconverter cohorts G Touloumi, N Pantazis, D Pillay, D Paraskevis, ML Chaix, HC Bucher, ... Clinical infectious diseases 56 (6), 888-897, 2013 | 134 | 2013 |
| Immunovirologic control 24 months after interruption of antiretroviral therapy initiated close to HIV seroconversion S Lodi, L Meyer, AD Kelleher, M Rosinska, J Ghosn, M Sannes, K Porter Archives of internal medicine 172 (16), 1252-1255, 2012 | 129 | 2012 |
| Gender differences in HIV progression to AIDS and death in industrialized countries: slower disease progression following HIV seroconversion in women I Jarrin, R Geskus, K Bhaskaran, M Prins, S Perez-Hoyos, R Muga, ... American journal of epidemiology 168 (5), 532-540, 2008 | 126 | 2008 |
| Using CD4 data to estimate HIV incidence, prevalence, and percent of undiagnosed infections in the United States R Song, HI Hall, TA Green, CL Szwarcwald, N Pantazis JAIDS Journal of Acquired Immune Deficiency Syndromes 74 (1), 3-9, 2017 | 125 | 2017 |
| Effect of HCV infection on cause-specific mortality after HIV seroconversion, before and after 1997 J van der Helm, R Geskus, C Sabin, L Meyer, J Del Amo, G Chêne, ... Gastroenterology 144 (4), 751-760. e2, 2013 | 120 | 2013 |
| Incidence and risk factors of HIV-related non-Hodgkin's lymphoma in the era of combination antiretroviral therapy: a European multicohort study Collaboration of Observational HIV Epidemiological Research Europe (COHERE ... Antiviral therapy 14 (8), 1065-1074, 2009 | 111 | 2009 |
| An evaluation of HIV elite controller definitions within a large seroconverter cohort collaboration AD Olson, L Meyer, M Prins, R Thiebaut, D Gurdasani, M Guiguet, ... PloS one 9 (1), e86719, 2014 | 108 | 2014 |
| Quantitation of human immunodeficiency virus type 1 DNA forms with the second template switch in peripheral blood cells predicts disease progression independently of plasma RNA … LG Kostrikis, G Touloumi, R Karanicolas, N Pantazis, C Anastassopoulou, ... Journal of virology 76 (20), 10099-10108, 2002 | 108 | 2002 |
| Current CD4 cell count and the short-term risk of AIDS and death before the availability of effective antiretroviral therapy in HIV-infected children and adults D Dunn, P Woodburn, T Duong, J Peto, A Phillips, D Gibb, K Porter, ... The Journal of infectious diseases 197 (3), 398-404, 2008 | 98 | 2008 |
